Vir Biotechnology, Inc. VIR Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$437.99M+16.1% | -$521.96M+15.1% | -$615.12M— | —— | ||
| $11.68M-19.8% | $14.56M-24.2% | $19.22M+180% | $6.87M+28.3% | ||
| $49.07M-37.5% | $78.46M-29.5% | $111.32M+9.0% | $102.08M+21.8% | ||
| —— | -$988K— | —— | —— | ||
| —— | —— | -$358.84M— | —— | ||
| —— | —— | —— | $39.36M+974% | ||
| -$7.37M+68.0% | -$23.03M-76.5% | -$13.05M-137% | -$5.5M-928% | ||
| -$391.78M+12.2% | -$446.35M+42.7% | -$778.79M-147% | $1.66B— | ||
| $4.83M-33.8% | $7.3M-66.2% | $21.57M-68.3% | $68.01M+212% | ||
| $886.33M-28.3% | $1.24B-38.7% | $2.02B+36.5% | $1.48B+251% | ||
| $1.2B-30.9% | $1.74B-21.1% | $2.2B+527% | $351.51M+16.7% | ||
| $310.37M-37.8% | $499.37M— | —— | -$1.19B-748% | ||
| $1.35M+70.8% | $790K-77.3% | $3.48M— | $0— | ||
| $3.79M-13.7% | $4.39M-41.3% | $7.48M-78.5% | $34.76M-65.4% | ||
| —— | —— | -$606.68M— | —— | ||
| -$9.47M-75.5% | -$5.4M— | —— | $8.94M— | ||
| —— | —— | -$910K— | —— | ||
| $11.57M-18.2% | $14.15M+1,282% | $1.02M— | —— | ||
| —— | —— | -$358.84M— | —— | ||
| -$7.37M+68.0% | -$23.03M-76.5% | -$13.05M-137% | -$5.5M-928% | ||
| $12.64M— | —— | -$2.16M-118% | $11.98M+708% | ||
| —— | —— | —— | $39.36M+974% | ||
| $4.98M-5.1% | $5.25M-31.5% | $7.66M-12.1% | $8.71M+41.1% | ||
| $1.2B-30.9% | $1.74B-21.1% | $2.2B+527% | $351.51M+16.7% | ||
| —— | $3.37M— | $0— | —— | ||
| —— | —— | $21.89M-81.8% | $120.02M— | ||
| -$7.37M+68.0% | -$23.03M-76.5% | -$13.05M-137% | -$5.5M-928% | ||
| -$396.61M+12.6% | -$453.65M+43.3% | -$800.36M-150% | $1.6B+2,398% | ||
| -$396.61M+12.6% | -$453.65M+43.3% | -$800.36M-150% | $1.6B+2,398% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vir Biotechnology, Inc. generate?
- Vir Biotechnology, Inc. (VIR) generated -$446.1M in operating cash flow over the trailing twelve months.
- What is Vir Biotechnology, Inc.'s free cash flow?
- After $3.6M of capital expenditures, Vir Biotechnology, Inc.'s free cash flow was -$449.6M over the trailing twelve months, down 6.5% year over year.
- Where does Vir Biotechnology, Inc.'s cash flow data come from?
- Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
